Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Liabilities (2019 - 2025)

Historic Total Liabilities for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $373.1 million.

  • Harmony Biosciences Holdings' Total Liabilities rose 1260.49% to $373.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $373.1 million, marking a year-over-year increase of 1260.49%. This contributed to the annual value of $340.0 million for FY2024, which is 128.06% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Total Liabilities stood at $373.1 million, which was up 1260.49% from $334.9 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Total Liabilities registered a high of $373.1 million during Q3 2025, and its lowest value of $229.4 million during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $296.4 million (2023), whereas its average is $293.7 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Total Liabilities crashed by 2514.69% in 2021 and then skyrocketed by 2709.05% in 2023.
  • Harmony Biosciences Holdings' Total Liabilities (Quarter) stood at $246.9 million in 2021, then increased by 9.76% to $271.0 million in 2022, then increased by 27.09% to $344.5 million in 2023, then dropped by 1.28% to $340.0 million in 2024, then rose by 9.72% to $373.1 million in 2025.
  • Its Total Liabilities stands at $373.1 million for Q3 2025, versus $334.9 million for Q2 2025 and $335.0 million for Q1 2025.